Debating the evidence: Oral contraceptives containing drospirenone and risk of blood clots

Current Drug Safety

Volumn 6, Issue 3, 2011, Pages 132-133

  Dodd, Seetal ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE; ESTROGEN; GESTAGEN;

BLOOD CLOTTING; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; VENOUS THROMBOEMBOLISM;

ANDROSTENES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 80054120442     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488611797579285     Document Type: Editorial

References (8)

1. Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 2011; 342: d2139.
2. Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 2011; 342: d2151.
3. Shapiro S, Dinger J. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies. J Fam Plann Reprod Health Care 2011; 36 (1): 33-8.
4. Dinger J, Assmann A, Mohner S, Minh TD. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Fam Plann Reprod Health Care 2010; 36(3): 123-9.
5. Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick SS. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis. BMJ 2000; 321(7270): 1190-5.
6. Nightingale AL, Lawrenson RA, Simpson EL, Williams TJ, MacRae KD, Farmer RD. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care 2000; 5(4): 265-74.
7. The U.S. Food and Drug Administration 2011.
8. Reid R. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update. J Obstet Gynaecol Can 2011; 32(12): 1192-204.